Phase 4
Completed N=119
Clinical Investigation of the Vision-R800 Device.
Source: ClinicalTrials.gov NCT04208750 ↗Enrolled (actual)
119
Serious AEs
0.0%
Results posted
Mar 2022
Primary outcomePrimary: Subjective Questionnaire Response — 22; 32; 5; 3 Participants
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Randomized, bilateral, cross-over dispensing study of a standard and VR800 refraction and associated spectacle lenses.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Subjective Questionnaire Response |
22; 32; 5; 3; 15; 11 | — |
Eligibility Criteria
Inclusion Criteria
- current adaptated progressive addition lens wearer, if bifocal lens required
- wearable pair of glasses < 2 years old
- wear glasses at least 6 hours per day
Exclusion Criteria
- Eye Disease with an impact on visual acuity or binocular vision abnormalities (by self-report)
- Formal training in optometry, vision science or in the eyecare field
Data sourced from ClinicalTrials.gov (NCT04208750). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.